AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M

The global licensing deal also includes exclusive rights for other undisclosed inflammatory and respiratory diseases.

LocalNews LocalNews
Nov 29, 2022 - 01:00
0 7
AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M
The global licensing deal also includes exclusive rights for other undisclosed inflammatory and respiratory diseases.
Read More